NPI: 1003315011
| Year | Claims | Total Paid |
|---|---|---|
| 2020 | 36 | $345.09 |
| 2021 | 42 | $16K |
| 2022 | 163 | $151K |
| 2023 | 268 | $320K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J2315 | Injection, naltrexone, depot form, 1 mg | 380 | 324 | $485K |
| A4221 | Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately) | 113 | 98 | $2K |
| M0244 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency | 16 | 16 | $677.30 |